This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Achieve Life Sciences (ACHV) Gets a Buy from H.C. Wainwright

Tipranks - Tipranks - Wed May 13, 11:40AM CDT

In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Achieve Life Sciences, with a price target of $12.00.

Claim 55% Off TipRanks

According to TipRanks, Folkes is a 3-star analyst with an average return of 2.0% and a 42.07% success rate. Folkes covers the Healthcare sector, focusing on stocks such as Heron Therapeutics, Collegium Pharmaceutical, and Achieve Life Sciences.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Achieve Life Sciences with a $13.20 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on Achieve Life Sciences’ latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $14.66 million. In comparison, last year the company had a GAAP net loss of $12.36 million

Read More on ACHV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).